Meanwhile, the enhanced activity of IP3R was detected in different models of neurodegenerative disorders, including HD, SCAs, and Alzheimer’s disease (Egorova and Bezprozvanny, 2018; Hisatsune et al., 2018). This evidence concerns the gene ITPR1 and Huntington disease.